Indraprastha Medical Corporation Ltd.
NSE: INDRAMEDCO | BSE: 532150
₹364.50
₹4.40
(1.22%)
As on 19-May-2026 10:39IST
Market cap
₹3,301 Cr
Revenue (TTM)
₹1,483 Cr
P/E Ratio
18
P/B Ratio
4.5
Div. Yield
1.1 %
Quality Score
10/10
Growth Score
7/10
Valuation Score
6/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹184 Cr
-
ROE
30 %
-
ROCE
41.4 %
-
Industry P/E
53.26
-
EV/EBITDA
10.3
-
Debt to Equity
0
-
Book Value
₹80.8
-
EPS
₹20
-
Face value
10
-
Shares outstanding
91,673,000
10 Years Aggregate
CFO
₹921.72 Cr
EBITDA
₹1,141.04 Cr
Net Profit
₹575.87 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indraprastha Med
| -18.7 | -14.7 | -13.6 | -17.2 | 63.6 | 34.0 | 20.8 |
|
BSE Healthcare
| 9.9 | 9.8 | 10.2 | 12.5 | 27.7 | 14.6 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Indraprastha Med
| -17.3 | 192.9 | 107.5 | 9.1 | 32.8 | 41.5 | 0.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indraprastha Med
|
364.5 | 3,300.7 | 1,482.5 | 183.6 | 15.1 | 26.3 | 18 | 4.5 |
| 279.6 | 4,317.8 | 1,081.2 | 103.7 | 13.0 | 11.7 | 41.7 | 5.0 | |
| 198.0 | 384.6 | 171.9 | 16.7 | 12.9 | 17.9 | 23.1 | 3.9 | |
| 750.9 | 39,123.3 | 4,643.2 | 464.1 | 13.7 | 8.9 | 100.8 | 8.6 | |
| 6.8 | 10.3 | 0.8 | 0.1 | 4.7 | 0.6 | 245.6 | 1.0 | |
| 3.2 | 17.3 | 0.2 | -8.7 | -2,034.3 | -50 | -- | 3.6 | |
| 54.8 | 99.0 | 0.1 | 4.1 | -3,152.0 | 12 | 23.9 | 2.9 | |
| 143.0 | 1,133.2 | 472.6 | 42.2 | 12.1 | 16.1 | 26.8 | 4.3 | |
| 1,347.3 | 8,797.0 | 1,494.5 | 194.1 | 17.1 | 13.2 | 45.3 | 5.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Indraprastha Med
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental... and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India. Read more
-
Incorporated
1988
-
Chairman
--
-
Managing Director
Shivakumar Pattabhiraman
-
Group
Apollo Hospitals
-
Headquarters
New Delhi, Delhi
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Indraprastha Med
What is the current share price of Indraprastha Medical Corporation Ltd Today?
The share price of Indraprastha Medical Corporation Ltd is ₹364.50 (NSE) and ₹365.10 (BSE) as of 19-May-2026 10:39 IST. Indraprastha Medical Corporation Ltd has given a return of 63.63% in the last 3 years.
What is the current PB & PE ratio of Indraprastha Medical Corporation Ltd?
The P/E ratio of Indraprastha Medical Corporation Ltd is 17.98 times as on 18-May-2026, a 66 discount to its peers’ median range of 53.26 times.
The P/B ratio of Indraprastha Medical Corporation Ltd is 4.46 times as on 18-May-2026, a 40 discount to its peers’ median range of 7.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.98
|
5.93
|
|
2024
|
12.70
|
3.30
|
|
2023
|
8.27
|
1.88
|
|
2022
|
9.14
|
1.65
|
|
2021
|
211.45
|
1.81
|
What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?
The 52-week high and low of Indraprastha Medical Corporation Ltd are Rs 640.85 and Rs 342.00 as of 19-May-2026.
What is the market cap of Indraprastha Medical Corporation Ltd?
Indraprastha Medical Corporation Ltd has a market capitalisation of ₹ 3,301 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Indraprastha Medical Corporation Ltd?
Before investing in Indraprastha Medical Corporation Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.